Dividends Calendar Earnings Calendar

UBX | Unity Biotechnology, Inc.

Unity Biotechnology, Inc.

Company profile

  • Industry: Biotechnology
  • Sector: Healthcare
  • Headquarters:   Brisbane, California, United States
  • Number of employees::   70 (2018)

Company profile

UNITY Biotechnology is developing therapeutics to extend human healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases.

About the Company

Unity Biotechnology is a startup biotechnology company that develops drugs which target senescent cells. The company's products in development include UBX0101, targeting knee osteoarthritis, and UBX1967, a preclinical product targeting ophthalmologic diseases. Both are senolytic medicines.


    3280 Bayshore Boulevard
    Suite 100
    Brisbane, CA 94005
    United States

      Key Persons / Board of Directors

      • CEO :  Anirvan Ghosh

      Jump to (Finance sites)

      Their Official Profiles 


      Other stocks 

      orcl urbn wfc cmg vale cag ntap low mdt dva vfc mrvl 

      Support this project

      If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
      More features coming soon :)

      Social Media 

      Recommended Books

      The Intelligent Investor
      Buy on Amazon

      Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

      The best book on investing ever written.
      -- Warren Buffet